Multiple Sclerosis Clinical Trial

Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis

Summary

The purpose of this study is to investigate the capacity of a 6-week treatment with neuromuscular electrical stimulation to improve walking in individuals whose mobility has been compromised by multiple sclerosis.

View Full Description

Full Description

Participants will be randomly assigned to one of two study arms. Those in one arm will receive a treatment with narrow stimulus pulses (0.4 ms) and those in the other arm will receive wide stimulus pulses (1 ms). The electrical stimulation will be delivered with a Vectra Genisys System.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Able to read, understand, and speak English to ensure safe participation in the project
Difficulties with walking
On stable doses of Ampyra, provigil, or other symptomatic-treating medications
No systemic steroids within the last 30 days
Not currently exercising more than 2x/wk
Able to arrange own transportation to and from the laboratories
Provide informed consent, including willingness to be randomly assigned to one of the two groups

Exclusion Criteria:

Documented MS-related relapse in the last 3 months
Medical diagnosis or condition that is considered to be an absolute or relative contraindication to participating in exercise training, such as major renal, pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer (other than treated basal cell cancer), other neurological disorders, or pregnancy
Poorly controlled diabetes mellitus or hypertension
History of seizure disorders
Alcohol dependence or abuse (≥2 drinks/day), or present history (last 6 months) of drug abuse
Inability to attend exercise sessions 3 days per week for 6 weeks

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

29

Study ID:

NCT02152085

Recruitment Status:

Completed

Sponsor:

University of Colorado, Boulder

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Colorado
Boulder Colorado, 80309, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

29

Study ID:

NCT02152085

Recruitment Status:

Completed

Sponsor:


University of Colorado, Boulder

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider